Gaurav Chandra
Director/Board Member bei ENZOLYTICS, INC.
Profil
Gaurav Chandra is currently the Chief Executive Officer at Biogenysis, Inc., the Director at Enzolytics, Inc. starting in 2024, and the Chief Operating Officer at Bioclonetics Immunotherapeutics, Inc. In terms of education, Dr. Chandra holds a doctorate degree from Albert Einstein College of Medicine, Inc., an undergraduate degree from Kasturba Medical College, and an MBA from the University of Colorado Denver.
Aktive Positionen von Gaurav Chandra
Unternehmen | Position | Beginn |
---|---|---|
ENZOLYTICS, INC. | Director/Board Member | - |
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Bioclonetics Immunotherapeutics, Inc. is a biotechnology company. It produces human IgG1 mono clinical antibodies for treating infectious diseases with non toxic passive immunotherapy. The company was founded by Joseph Cotropia and is headquartered in Heath, TX. | Chief Operating Officer | - |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Enzolytics, Inc., Biogenysis, Inc. engages in the research and development of species specific monoclonal antibodies against diseases. The private company is based in Dallas, TX. The CEO of the company is Gaurav Chandra. | Chief Executive Officer | - |
Ausbildung von Gaurav Chandra
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Kasturba Medical College | Undergraduate Degree |
University of Colorado Denver | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ENZOLYTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Bioclonetics Immunotherapeutics, Inc. is a biotechnology company. It produces human IgG1 mono clinical antibodies for treating infectious diseases with non toxic passive immunotherapy. The company was founded by Joseph Cotropia and is headquartered in Heath, TX. | Health Technology |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Enzolytics, Inc., Biogenysis, Inc. engages in the research and development of species specific monoclonal antibodies against diseases. The private company is based in Dallas, TX. The CEO of the company is Gaurav Chandra. | Commercial Services |